Document Type : Original Research


1 Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

2 Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya

3 Pathology Department, Faculty of Medicine, Zagazig University,Egypt

4 Department of Basic Medical Sciences, Unaizah College of Medicine and Medical Sciences, Qassim University, Unaizah, Kingdom of Saudi Arabia.

5 Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt

6 Department of General Surgery, Faculty of Medicine, Zagazig University Zagazig, Egypt

7 Department of Gynecology and Obstetrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt

8 Department of Obstetrics and Gynecology, College of Medicine, Jouf University, Sakaka, Kingdom of Saudi Arabia

9 Department of Gynecology and Obstetrics, Zagazig University Faculty of Medicine, Zagazig, Egypt



Background: Cervical cancer spreads to the pelvic lymph nodes, leading to a high incidence of cancer recurrence and unfavorable survival rates. Therefore, there is an urgent need to detect new predictive biomarkers for the early assessment of pelvic lymph node status in patients with cervical cancer. Fatty acid binding protein 4 (FABP4) is an intracellular lipid chaperone that can carry fatty acids to many organelles. Subunit 2 of the GINS complex (GINS2), which belongs to the GINS complex family, encodes a protein that initiates DNA replication and controls the cell cycle and normal cell division. Chromobox homolog 7 (CBX7) was found to promote cancer occurrence and spread through the promotion of EMT.
Objective: The current study aimed to assess the expression of FABP4, GINS2, and CBX7 in cancer cervix tissue to detect their prognostic and predictive roles in the development of lymph node metastases in cancer cervix patients
Methods: we collected tissues from patients with cancer cervix and evaluated the expression of FABP4, GINS2, and CBX7 using immunohistochemistry. We evaluated the association between their expression and clinicopathological and prognostic parameters.
Results: high expression of FABP4 and GINS2, in addition to low expression of CBX7, was positively associated with the old age group, large tumor size, high grade and lymphovascular involvement, para-uterine organ infiltration, advanced FIGO stage, chemotherapeutic resistance, and tumor recurrence.
Conclusion: We demonstrated the oncogenic roles of FABP4 and GISN2 in addition to the on-co-suppressive roles of CBX7 in cervical cancer and their association with poor clinicopathological criteria and poor survival. Our results indicated that FABP4, GISN2, and CBX7 could be considered predictive biomarkers of the occurrence of lymph node metastases in the cancer cervix preoperatively, which could be beneficial in the accurate preoperative design therapy.


Main Subjects

  1. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524-48.
  2. Hong K-S, Ju W, Choi HJ, Kim JK, Kim M-h, Cho K-SJIJoGC. Differential diagnostic performance of magnetic resonance imaging in the detection of lymph node metastases according to the tumor size in early-stage cervical cancer patients. Int J Gynecol Cancer. 2010;20(5). [DOI:10.1111/IGC.0b013e3181db5140] [PMID]
  3. Meva J, Chaudhary RK, Bhaduri D, Bhatia M, Hatti S, Ba RJIJoGC. Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator. Int J Gynecol Cancer. 2013;23(6). [DOI:10.1097/IGC.0b013e31829783c4] [PMID]
  4. Cibula D, Dostalek L, Hillemanns P, Scambia G, Jarkovsky J, Persson J, et al. Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study. Euro J Cancer. 2021;143:88-100. [DOI:10.1016/j.ejca.2020.10.037] [PMID]
  5. Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Virchows Archiv. 2018 Jun;472:919-36. [DOI:10.1007/s00428-018-2362-9] [PMID]
  6. Li G, Wu Q, Gong L, Xu X, Cai J, Xu L, et al. FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer. Cancer Cell Int. 2021;21(1):1-5. [DOI:10.1186/s12935-021-02273-4] [PMID]
  7. Ouyang F, Liu J, Xia M, Lin C, Wu X, Ye L, et al. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer Corrigendum in/10.3892/or. 2021.8016. Oncol Rep. 2017;37(5):2652-62. [DOI:10.3892/or.2017.5573] [PMID]
  8. Zimmerman AW, Veerkamp JH. New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci. 2002;59:1096-116. [DOI:10.1007/s00018-002-8490-y] [PMID]
  9. Tian W, Zhang W, Zhang Y, Zhu T, Hua Y, Li H, et al. FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport. Cancer Cell Int. 2020 Dec;20:1-3. [DOI:10.1186/s12935-020-01582-4] [PMID]
  10. Zheng M, Zhou Y, Yang X, Tang J, Wei D, Zhang Y, et al. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients. Breast Cancer Res and Treat. 2014;148:423-36. [DOI:10.1007/s10549-014-3172-7] [PMID]
  11. Tian P, Zhang C, Ma C, Ding L, Tao N, Ning L, et al. Decreased chromobox homologue 7 expression is associated with epithelial-mesenchymal transition and poor prognosis in cervical cancer. Open Med. 2021;16(1):410-8. [DOI:10.1515/med-2021-0015] [PMID]
  12. Ahmed MM, Gebriel MG, Morad EA, Saber IM, Elwan A, Salah M, et al. Expression of immune checkpoint regulators, cytotoxic T-lymphocyte antigen-4, and programmed death-ligand 1 in Epstein-Barr virus-associated nasopharyngeal carcinoma. Appl Immunohistochem Mol Morphol. 2021;29(6):401-8. [DOI:10.1097/PAI.0000000000000903] [PMID]
  13. Alabiad MA, Elderey MS, Shalaby AM, Nosery Y, Gobran MAJAI, Morphology M. The Usefulness of 4 Immunoperoxidase Stains Applied to Urinary Cytology Samples in the Pathologic Stage of Urothelial Carcinoma: A Study With Histologic Correlation. Appl Immunohistochem Mol Morphol. 2021;29(6):422-32. [DOI:10.1097/PAI.0000000000000905] [PMID]
  14. Elsalam SA, Mansor AE, Sarhan MH, Shalaby AM, Gobran MA, Alabiad MAJIJoGP. Evaluation of apoptosis, proliferation, and adhesion molecule expression in trophoblastic tissue of women with recurrent spontaneous abortion and infected with Toxoplasma gondii. Int J Gynecol Pathol. 2021;40(2):124-33. [DOI:10.1097/PGP.0000000000000683] [PMID]
  15. Alabiad MA, Harb OA, Taha HF, El Shafaay BS, Gertallah LM, Salama NJP, et al. Prognostic and clinic-pathological significances of SCF and COX-2 expression in inflammatory and malignant prostatic lesions. Pathol Oncol Res. 2019;25:611-24. [DOI:10.1007/s12253-018-0534-1] [PMID]
  16. Tawfeek SE, Shalaby AM, Alabiad MA, Albackoosh A-AAA, Albakoush KMM, Omira MMAJT, et al. Metanil yellow promotes oxidative stress, astrogliosis, and apoptosis in the cerebellar cortex of adult male rat with possible protective effect of scutellarin: a histological and immunohistochemical study. Tissue Cell. 2021;73:101624. [DOI:10.1016/j.tice.2021.101624] [PMID]
  17. Alabiad MA, Harb OA, Hefzi N, Ahmed RZ, Osman G, Shalaby AM, et al. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma. Exp Mol Pathol. 2021;122:104670. [DOI:10.1016/j.yexmp.2021.104670] [PMID]
  18. Widschwendter P, Janni W, Scholz C, De Gregorio A, De Gregorio N, Friedl TWJAoG, et al. Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer. Arch Gynecol Obstet. 2019;300:1709-18. [DOI:10.1007/s00404-019-05341-3] [PMID]
  19. Nanthamongkolkul K, Hanprasertpong JJOr, treatment. Predictive factors of pelvic lymph node metastasis in early-stage cervical cancer. Oncol Res Treat. 2018;41(4):194-8. [DOI:10.1159/000485840] [PMID]
  20. Cai J, He X, Wang H, Dong W, Zhang Y, Zhao J, et al. Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes. Radiat Oncol. 2021;16(1):1-0. [DOI:10.1186/s13014-021-01781-x] [PMID]
  21. Bahrami A, Hasanzadeh M, Shahidsales S, Farazestanian M, Hassanian SM, Moetamani Ahmadi M, et al. Genetic susceptibility in cervical cancer: from bench to bedside. J Cell Physiol. 2018;233(3):1929-39. [DOI:10.1002/jcp.26019] [PMID]
  22. Guaita‐Esteruelas S, Bosquet A, Saavedra P, Guma J, Girona J, Lam EWF, et al. Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins. Mol Carcinogen. 2017;56(1):208-17. [DOI:10.1002/mc.22485] [PMID]
  23. Zhang Y, Zhang W, Min X, Zhujun X, Fangmei A, Qiang Z, et al. High expression of FABP4 in colorectal cancer and its clinical significance. J Zhejiang Univ Sci B. 2021;22:136-45. [DOI:10.1631/jzus.B2000366] [PMID]
  24. Luo Y, Yang Z, Li D, Liu Z, Yang L, Zou Q, et al. LDHB and FABP4 are associated with progression and poor prognosis of pancreatic ductal adenocarcinomas. Appl Immunohistochem Mol Morphol. 2017 May 1;25(5):351-7. [DOI:10.1097/PAI.0000000000000306] [PMID]
  25. Zhong CQ, Zhang XP, Ma N, Zhang EB, Li JJ, Jiang YB, et al. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma. Cancer Med. 2018;7(6):2629-40. [DOI:10.1002/cam4.1511] [PMID]
  26. Liu M, Pan H, Zhang F, Zhang Y, Zhang Y, Xia H, et al. Identification of TNM stage-specific genes in lung adenocarcinoma by genome-wide expression profiling. Oncol Lett. 2013;6(3):763-8. [DOI:10.3892/ol.2013.1469] [PMID]
  27. Tane S, Sakai Y, Hokka D, Okuma H, Ogawa H, Tanaka Y, et al. Significant role of Psf3 expression in non‐small‐cell lung cancer. Cancer Sci. 2015;106(11):1625-34. [DOI:10.1111/cas.12770] [PMID]
  28. Selman TJ, Mann C, Zamora J, Appleyard T-L, Khan KJC. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. Can Med Assoc J. 2008;178(7):855-62. [DOI:10.1503/cmaj.071124] [PMID]
  29. Matsuura Y, Kawagoe T, Toki N, Tanaka M, Kashimura MJIJoGC. Long-standing complications after treatment for cancer of the uterine cervix-clinical significance of medical examination at 5 years after treatment. Int J Gynecol Cancer. 2006;16(1). [DOI:10.1111/j.1525-1438.2006.00354.x] [PMID]
  30. Altgassen C, Hertel H, Brandstädt A, Köhler C, Dürst M, Schneider AJJoCO. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol. 2008;26(18):2943-51. [DOI:10.1200/JCO.2007.13.8933] [PMID]
  31. Sláma J, Dundr P, Dusek L, Cibula DJGo. High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol. 2013;129(2):384-8. [DOI:10.1016/j.ygyno.2013.02.001] [PMID]
  32. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. New Eng J Med. 2018;379(20):1895-904. [DOI:10.1056/NEJMoa1806395] [PMID]
  33. Yu T, Wu Y, Hu Q, Zhang J, Nie E, Wu W, et al. CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1. Oncotarget. 2017;8(16):26637. [DOI:10.18632/oncotarget.15789] [PMID]
  34. Ni S-J, Zhao L-Q, Wang X-F, Wu Z-H, Hua R-X, Wan C-H, et al. CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways. J Hematol Oncol. 2018;11:1-4. [DOI:10.1186/s13045-018-0562-z] [PMID]
  35. Bao Z, Xu X, Liu Y, Chao H, Lin C, Li Z, et al. CBX7 negatively regulates migration and invasion in glioma via Wnt/β-catenin pathway inactivation. 2017;8(24):39048. [DOI:10.18632/oncotarget.16587] [PMID]
  36. Wang H, Liu W, Black S, Turner O, Daniel JM, Dean-Colomb W, et al. Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression. 2016;7(5):5677. [DOI:10.18632/oncotarget.6801] [PMID]
  37. Federico A, Sepe R, Cozzolino F, Piccolo C, Iannone C, Iacobucci I, et al. The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms. 2019 Apr 1;1862(4):509-21. [DOI:10.1016/j.bbagrm.2019.02.006] [PMID]
  38. Sepe R, Formisano U, Federico A, Forzati F, Bastos AU, D'Angelo D, et al. CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression. Oncotarget. 2015;6(5):2680. [DOI:10.18632/oncotarget.2777] [PMID]

39. Shinjo K, Yamashita Y, Yamamoto E, Akatsuka S, Uno N, Kamiya A, et al. Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL‐induced apoptotic pathway regulation. Int J Cancer. 2014;135(2):308-18. [DOI:10.1002/ijc.28692] [PMID]